DAM
OACCW

DLD Asset Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

DLD Asset Management’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,519
Closed -$31.6K – 489
2025
Q4 		$31.6K Buy
+44,519
New +$37.2K ﹤0.01% 326

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

DLD Asset Management's OACCW Position: Q1 2026 in Review

DLD Asset Management sold out of Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) in Q1 2026, closing a stake of 44,519 shares — an estimated $31.6K sold.

DLD Asset Management first reported a position in OACCW in Q4 2025 and held it in 1 quarter. The position peaked at $31.6K in Q4 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • DLD Asset Management reported no remaining Oaktree Acquisition Corp III Life Sciences Warrant position as of Q1 2026 after selling out during the quarter.
  • DLD Asset Management sold 44,519 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $31.6K.
  • DLD Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2025 and held it in 1 quarter.
  • DLD Asset Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $31.6K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on DLD Asset Management's 13F filing for Q1 2026, filed 13 May 2026.